Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SVRA | ALT | TRML | ||
| Company | Savara Inc | Altimmune Inc | Tourmaline Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.20 | 8.31 | 20.22 | ||
| High | 3.33 | 8.75 | 21.53 | ||
| Low | 3.12 | 8.18 | 20.20 | ||
| Last | 3.23 | 8.25 | 20.65 | ||
| Change | unch | +0.07 | +0.31 | ||
| % Change | unch | +0.86% | +1.52% | ||
| Volume | 2,253,300 | 4,899,400 | 848,700 | ||
| 20-Day Average Volume | 1,420,010 | 3,367,230 | 215,750 | ||
| Previous Close | 3.23 | 8.18 | 20.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.38 | 8.77 | 23.59 | ||
| 20-Day Raw Stochastic | 28.74% | 17.18% | 19.76% | ||
| 20-Day Relative Strength | 45.13% | 50.18% | 39.45% | ||
| Weighted Alpha | -33.64 | -12.96 | +10.70 | ||
| Today's Opinion | 100% Sell | 72% Buy | 24% Buy | ||
| Previous Opinion | 100% Sell | 72% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.62% since 12/13/24 | -8.64% since 12/13/24 | -5.32% since 12/13/24 | ||
| Low | 2.99 on 12/18/24 | 7.70 on 12/18/24 | 19.14 on 12/19/24 | ||
| High | 3.39 on 12/16/24 | 9.59 on 12/16/24 | 22.80 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +3.19% since 11/20/24 | +2.48% since 11/20/24 | -13.96% since 11/20/24 | ||
| Low | 2.99 on 12/18/24 | 7.70 on 12/18/24 | 19.14 on 12/19/24 | ||
| High | 3.83 on 12/06/24 | 10.88 on 12/04/24 | 26.78 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | -28.06% since 09/20/24 | +5.91% since 09/20/24 | -10.30% since 09/20/24 | ||
| Low | 2.82 on 11/18/24 | 5.86 on 10/01/24 | 19.14 on 12/19/24 | ||
| High | 4.70 on 09/23/24 | 11.16 on 11/13/24 | 29.79 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | -13.17% since 06/20/24 | +38.89% since 06/20/24 | +36.66% since 06/20/24 | ||
| Low | 2.82 on 11/18/24 | 5.28 on 08/05/24 | 12.12 on 07/05/24 | ||
| High | 5.11 on 07/12/24 | 11.16 on 11/13/24 | 29.79 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 554,329 | 586,781 | 529,528 | ||
| Shares Outstanding, K | 171,619 | 71,125 | 25,643 | ||
| Annual Sales | 0 | 430,000 | 0 | ||
| Annual Net Income | -54,700,000 | -88,450,000 | -42,120,000 | ||
| Last Quarter Sales | 0 | 10,000 | 0 | ||
| Last Quarter Net Income | -24,250,000 | -22,850,000 | -20,180,000 | ||
| 60-Month Beta | 0.92 | 0.15 | 2.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/12/24 | -0.32 on 11/12/24 | -0.78 on 11/07/24 | ||
| Latest Earnings Date | 11/14/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | 2.910 on 02/06/17 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||